Single Human Embryo Transfer in Assisted Reproduction Programs

NCT ID: NCT01471951

Last Updated: 2011-11-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

EARLY_PHASE1

Total Enrollment

154 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Embryo selection based on the use of morphometric parameters should increase the implantation success rate.

One of the most important issues of "Assisted Reproduction Technologies (ART)" is the possibility of multiple pregnancies which carries a significant risk for maternal-fetal health. These risks can be reduced by restricting the number of embryos transferred.

To do this, it is essential to improve current techniques of embryo selection by developing new tools that would allow the selection of the embryos with higher implantation potential. In previous works (Molina et al 2011) the investigators have demonstrated greater efficacy for the embryo classification systems based on the use of the morphometric variables. The investigators have also developed a profile of embryo implantation using these morphometric variables. In this project the investigators intend to validate the clinical validity of this new embryo classification system by conducting a prospective study of single embryo transfer (SET) in young women at risk of multiple pregnancies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Pregnancies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

single embryo transfer

Group Type EXPERIMENTAL

Single embryo transfer in women at risk of multiple pregnancies

Intervention Type OTHER

Prospective study of single embryo transfers in selected women with good reproductive prognosis and high risk of multiple pregnancies in an IVF-ICSI program.. The day of the embryo transfer, the patients will be randomized by a computer application for morphological and morphometric embryo selection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Single embryo transfer in women at risk of multiple pregnancies

Prospective study of single embryo transfers in selected women with good reproductive prognosis and high risk of multiple pregnancies in an IVF-ICSI program.. The day of the embryo transfer, the patients will be randomized by a computer application for morphological and morphometric embryo selection.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Personal and family history without interest, not toxic habits.
* Less than 35 years at the time of IVF-ICSI cycle
* Sterility of unknown origin or tubal obstruction.

Exclusion Criteria

* Repeat nonvoluntary abortions
* Endometriosis
* Polycystic ovary syndrome (criteria Rotterdam 2004)
* Severe male factor (REM \<1 million sperm / ml)
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundacion Para La Investigacion Hospital La Fe

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Inmaculada Molina Botella

Head biologist of the human reproduction unit

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose J Pertusa, Ph.D.

Role: STUDY_CHAIR

Director of the deparment of Biología Funcional y Análisis de Imagen

Antonio A Pellicer, Ph.D.

Role: STUDY_DIRECTOR

Head of Gynecology and Obstetrics

Inmaculada I Molina, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Embryologist of the Human Reproduction Unit

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitari La Fe

Valencia, Valencia, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Molina Botella, Ph.D.

Role: CONTACT

0034 961244660

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

FUNDACION PARA LA INVESTIGACION

Role: primary

+3496 386 27 58

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011/0329

Identifier Type: -

Identifier Source: org_study_id